Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0606920200280010074
Biomolecules & Therapeutics
2020 Volume.28 No. 1 p.74 ~ p.82
¥â-Amyrin Ameliorates Alzheimer¡¯s Disease-Like Aberrant Synaptic Plasticity in the Mouse Hippocampus
Park Hye-Jin

Kwon Hui-Young
Lee Ji-Hye
Cho Eun-Bi
Lee Young-Choon
Moon Min-Ho
Jun Mi-Ra
Kim Dong-Hyun
Jung Ji-Wook
Abstract
Alzheimer¡¯s disease (AD) is a progressive and most frequently diagnosed neurodegenerative disorder. However, there is still no drug preventing the progress of this disorder. ¥â-Amyrin, an ingredient of the surface wax of tomato fruit and dandelion coffee, is previously reported to ameliorate memory impairment induced by cholinergic dysfunction. Therefore, we tested whether ¥â-amyrin can prevent AD-like pathology. ¥â-Amyrin blocked amyloid ¥â (A¥â)-induced long-term potentiation (LTP) impairment in the hippocampal slices. Moreover, ¥â-amyrin improved A¥â-induced suppression of phosphatidylinositol-3-kinase (PI3K)/Akt signaling. LY294002, a PI3K inhibitor, blocked the effect of ¥â-amyrin on A¥â-induced LTP impairment. In in vivo experiments, we observed that ¥â-amyrin ameliorated object recognition memory deficit in A¥â-injected AD mice model. Moreover, neurogenesis impairments induced by A¥â was improved by ¥â-amyrin treatment. Taken together, ¥â-amyrin might be a good candidate of treatment or supplement for AD patients.
KEYWORD
¥â-amyrin, Amyloid ¥â, Alzheimer¡¯s disease, Synaptic plasticity
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed